Control of glutamate release by complexes of adenosine and cannabinoid receptors

scientific article published on 23 January 2020

Control of glutamate release by complexes of adenosine and cannabinoid receptors is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1186/S12915-020-0739-0
P932PMC publication ID6979073
P698PubMed publication ID31973708

P50authorRodrigo A. CunhaQ37838396
Sergi FerréQ39025293
Attila KöfalviQ42314748
Ana SebastiãoQ43269598
Ramon Guixà-GonzálezQ56955456
Francisco CiruelaQ59706012
Samira G FerreiraQ59869428
P2093author name stringVicent Casadó
Leonardo Pardo
Estefanía Moreno
Ning-Sheng Cai
Arnau Cordomí
Hideaki Yano
Victor Fernández-Dueñas
Marta Sánchez-Soto
Verònica Casadó-Anguera
P2860cites workPresynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromersQ24304896
Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function.Q24305024
Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptorsQ24630429
Preferred supramolecular organization and dimer interfaces of opioid receptors from simulated self-associationQ27319797
Crystal structure of the µ-opioid receptor bound to a morphinan antagonistQ27678133
Identification of a Gialpha binding site on type V adenylyl cyclaseQ28283385
Adenosine-cannabinoid receptor interactions. Implications for striatal functionQ28286488
Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clonesQ28326966
The adenosine A2A receptor interacts with the actin-binding protein alpha-actininQ28568384
Striatal adenosine A2A and cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoidsQ28571785
G proteins: transducers of receptor-generated signalsQ29547519
The molecular logic of endocannabinoid signallingQ29615356
In vivo protein transduction: delivery of a biologically active protein into the mouseQ29615482
CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatumQ31817073
Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cellsQ32065053
Actions of caffeine in the brain with special reference to factors that contribute to its widespread use.Q33537215
Bimolecular fluorescence complementation: lighting up seven transmembrane domain receptor signalling networksQ33690721
High-resolution crystal structure of the human CB1 cannabinoid receptorQ33694212
Interactions between intracellular domains as key determinants of the quaternary structure and function of receptor heteromersQ34094605
Toward a neurobiology of obsessive-compulsive disorderQ34122154
Functional selectivity of allosteric interactions within G protein-coupled receptor oligomers: the dopamine D1-D3 receptor heterotetramer.Q34186022
The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins.Q34245210
Metabotropic mGlu5 receptors regulate adenosine A2A receptor signalingQ34330621
The GPCR heterotetramer: challenging classical pharmacologyQ34463989
Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramerQ34481913
Mechanisms of the psychostimulant effects of caffeine: implications for substance use disordersQ34509861
Uncovering caffeine's adenosine A2A receptor inverse agonism in experimental parkinsonismQ34576218
From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatmentQ34632695
Presynaptic adenosine A2A receptors dampen cannabinoid CB1 receptor-mediated inhibition of corticostriatal glutamatergic transmissionQ35039222
CODA-RET reveals functional selectivity as a result of GPCR heteromerizationQ35171170
Dopamine D4 receptor, but not the ADHD-associated D4.7 variant, forms functional heteromers with the dopamine D2S receptor in the brainQ35560788
Modulation of striatal projection systems by dopamineQ36367283
A1R-A2AR heteromers coupled to Gs and G i/0 proteins modulate GABA transport into astrocytes.Q37131945
N terminus of type 5 adenylyl cyclase scaffolds Gs heterotrimerQ37444511
Key role of the dopamine D4 receptor in the modulation of corticostriatal glutamatergic neurotransmission.Q37580466
Effectiveness and tolerability of istradefylline for the treatment of restless legs syndrome: an exploratory study in five female patientsQ37672812
G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectivesQ37680849
Cortico-striatal circuits: Novel therapeutic targets for substance use disorders.Q38415873
How does adenosine control neuronal dysfunction and neurodegeneration?Q38882782
Singular Location and Signaling Profile of Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Dorsal Striatum.Q39013000
Pharmacology and structure of isolated conformations of the adenosine A₂A receptor define ligand efficacyQ39190700
Structure of the adenosine A(2A) receptor bound to an engineered G protein.Q39555371
Characterization of the A2AR-D2R interface: focus on the role of the C-terminal tail and the transmembrane helicesQ39637403
Dopamine D2 and 5-hydroxytryptamine 5-HT(₂A) receptors assemble into functionally interacting heteromers.Q39648976
Phospholipase Cbeta2 binds to and inhibits phospholipase Cdelta1.Q40499141
Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptorsQ40516448
Removal of the carboxy terminus of the A2A-adenosine receptor blunts constitutive activity: differential effect on cAMP accumulation and MAP kinase stimulationQ40703288
Serial millisecond crystallography for routine room-temperature structure determination at synchrotronsQ41052019
Modulation of Ca2+ channels by G-protein beta gamma subunitsQ41214714
Presynaptic inhibition of elicited neurotransmitter releaseQ41462648
Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal gangliaQ41624006
SIGNAL TRANSDUCTION. Structural basis for nucleotide exchange in heterotrimeric G proteinsQ42390741
Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease modelsQ42508054
Probing the activation-promoted structural rearrangements in preassembled receptor-G protein complexes.Q42595255
Facilitation of μ-opioid receptor activity by preventing δ-opioid receptor-mediated codegradation.Q44348937
Adenosine A2A receptors enable the synaptic effects of cannabinoid CB1 receptors in the rodent striatum.Q45922072
Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis.Q46384445
Cannabis for restless legs syndrome: a report of six patientsQ47715691
Adenosine receptors as markers of brain iron deficiency: Implications for Restless Legs SyndromeQ47818971
Targeting hypersensitive corticostriatal terminals in restless legs syndromeQ47952336
Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum.Q48217036
Chronic and acute adenosine A2A receptor blockade prevents long-term episodic memory disruption caused by acute cannabinoid CB1 receptor activation.Q50595120
Striatal adenosine-cannabinoid receptor interactions in rats over-expressing adenosine A2A receptors.Q50917064
Evidence for functional pre-coupled complexes of receptor heteromers and adenylyl cyclase.Q52338934
Cross-communication between Gi and Gs in a G-protein-coupled receptor heterotetramer guided by a receptor C-terminal domain.Q52372072
Detection of heteromers formed by cannabinoid CB1, dopamine D2, and adenosine A2A G-protein-coupled receptors by combining bimolecular fluorescence complementation and bioluminescence energy transfer.Q55035681
Cryo-EM structure of the adenosine A2A receptor coupled to an engineered heterotrimeric G protein.Q55072103
Revisiting the Functional Role of Dopamine D Receptor Gene Polymorphisms: Heteromerization-Dependent Gain of Function of the D Receptor VariantQ58568737
Remote control of movement disorders using a photoactive adenosine A2A receptor antagonistQ64868285
Mechanisms of proinflammatory cytokine-induced biphasic NF-kappaB activationQ79322514
In vivo visualization of actin dynamics and actin interactions by BiFCQ80272030
Treatment of restless legs syndrome/Willis-Ekbom disease with the non-selective ENT1/ENT2 inhibitor dipyridamole: testing the adenosine hypothesisQ88430570
Adenosine A1-Dopamine D1 Receptor Heteromers Control the Excitability of the Spinal MotoneuronQ88802477
Identifying G protein-coupled receptor dimers from crystal packingsQ89399485
Structure of a Signaling Cannabinoid Receptor 1-G Protein ComplexQ91028746
Crystal Structure of the Human Cannabinoid Receptor CB2Q91028754
Memory deficits induced by chronic cannabinoid exposure are prevented by adenosine A2AR receptor antagonismQ92135757
Biased G Protein-Independent Signaling of Dopamine D1-D3 Receptor Heteromers in the Nucleus AccumbensQ92664218
Adenosine mechanisms and hypersensitive corticostriatal terminals in restless legs syndrome. Rationale for the use of inhibitors of adenosine transportQ92957709
P433issue1
P304page(s)9
P577publication date2020-01-23
P1433published inBMC BiologyQ2545642
P1476titleControl of glutamate release by complexes of adenosine and cannabinoid receptors
P478volume18

Reverse relations

Q99721053A1 and A2A receptors modulate spontaneous adenosine but not mechanically-stimulated adenosine in the caudatecites workP2860

Search more.